The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs ...
3d
CareMed Has Been Selected as a National Specialty Pharmacy Provider for Exdensur (depemokimab-ulaa)
NEW HYDE PARK, N.Y., Jan. 29, 2026 (GLOBE NEWSWIRE) -- CareMed, an independent specialty pharmacy, has been selected as a pharmacy partner by GSK for Exdensur (depemokimab), indicated for the add-on ...
Though the arrangement does not fit squarely within a regulatory safe harbor, and therefore technically would generate (if ...
Jan 15 (Reuters) - Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools and automated labs to unlock efficiency gains across ...
Low levels of vitamin D seem to raise your risk of heart attack but scientists are still figuring out why—and whether supplements might help protect you. Vitamin D is thought to play a protective role ...
[Interpreted] [Operator Instructions] We'd like to start the presentation with Chris. We'd like to cover the business highlight, followed by Maeda to give the highlights of the Japanese business, and ...
Fintel reports that on October 29, 2025, D. Boral Capital maintained coverage of Medicus Pharma (NasdaqCM:MDCX) with a Buy recommendation. As of October 29, 2025, the average one-year price target for ...
Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today presented preclinical data related to the company’s cyclin ...
In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...
Fintel reports that on October 7, 2025, D. Boral Capital maintained coverage of Kairos Pharma (NYSEAM:KAPA) with a Buy recommendation. Analyst Price Forecast Suggests 585.48% Upside As of September 30 ...
It’s becoming increasingly clear that pharmaceutical companies can live with President Trump’s tariffs. What the industry can’t live with is uncertainty on drug prices. The sector has long traded at a ...
Pete Pharma announced it is partnering with Fabrx to bring the company's pharmaceutical 3D printing technology to the compounding pharmacy market in the United States. Fabrx's pharmaceutical 3D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results